MAD Study of NX210c

NCT05827653 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Elderly

Interventions

DRUG: NX210c
DRUG: Placebo

Sponsor

Axoltis Pharma

Collaborators

[object Object]